Piperazine- and Piperidine-Containing Thiazolo[5,4-<i>d</i>]pyrimidine Derivatives as New Potent and Selective Adenosine A<sub>2A</sub> Receptor Inverse Agonists

Piperazine- and Piperidine-Containing Thiazolo[5,4-<i>d</i>]pyrimidine Derivatives as New Potent and Selective Adenosine A<sub>2A</sub> Receptor Inverse Agonists

The therapeutic use of A<sub>2A</sub> adenosine receptor (AR) antagonists for the treatment of neurodegenerative disorders, such as Parkinson and Alzheimer diseases, is a very promising approach. Moreover, the potential therapeutic role of A<sub>2A</sub> AR antagonists to avo...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Flavia Varano, Daniela Catarzi, Erica Vigiani, Fabrizio Vincenzi, Silvia Pasquini, Katia Varani, Vittoria Colotta
Format: Artikel
Sprache:English
Veröffentlicht: MDPI AG 2020-07-01
Schriftenreihe:Pharmaceuticals
Schlagworte:
G protein-coupled receptors
adenosine receptors
adenosine A<sub>2A</sub> receptor ligands
thiazolo[5,4-<i>d</i>]pyrimidines
Online Zugang:https://www.mdpi.com/1424-8247/13/8/161

Online

https://www.mdpi.com/1424-8247/13/8/161

Ähnliche Einträge